Page last updated: 2024-12-10

metoxibutropate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID4464271
CHEMBL ID4795894
CHEBI ID135336
SCHEMBL ID5080304
MeSH IDM0073663

Synonyms (34)

Synonym
metoxibutropate
af-2259
flubenil
benflogin
ibuprofen guaiacol ester
methoxybutropate
2-methoxyphenyl 2-(4-isobutylphenyl)propionate
guaiacol 4-isobutylhydratropate
benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, 2-methoxyphenyl ester
2-methoxyphenyl alpha-methyl-4-(isobutyl)phenylacetate
brn 2664678
propionic acid, 2-(p-isobutylphenyl)-, o-methoxyphenyl ester
einecs 266-318-9
alpha-methyl-4-(2-methylpropyl)benzeneacetic acid 2-methoxyphenyl ester
2-(p-isobutylphenyl)propionic acid o-methoxyphenyl ester
af 2259
CHEBI:135336
66332-77-2
benflogin (tn)
D08213
(2-methoxyphenyl) 2-[4-(2-methylpropyl)phenyl]propanoate
unii-0n623mnk8z
0n623mnk8z ,
SCHEMBL5080304
ibuprofen guaiacol ester [who-dd]
AKOS027379916
2-methoxyphenyl 2-[4-(2-methylpropyl)phenyl]propanoate
DTXSID10984948
CHEMBL4795894
af 2259; methoxybutropate; metoxibutropate
Q27236986
EN300-18567259
Z3244866822
2-methoxyphenyl2-(4-isobutylphenyl)propanoate

Research Excerpts

Actions

ExcerptReferenceRelevance
"metoxibutropate) are able to inhibit in-vitro prostaglandin synthesis."( Effects of metoxibutropate, ibuprofen and guaiacol on the gastrointestinal system.
Bandi, GL; Bozzi, M; Formenti, A; Fossati, A; Passarotti, C; Vimercati, MG, 1991
)
1.39

Dosage Studied

ExcerptRelevanceReference
" The semialkaline proteolithic enzyme Seaprose S, available in 30 mg tablets was administered at a dosage of 3 tablets a day for a period of 8 days."( [Clinical effectiveness and safety of Seaprose S in the treatment of complications of puerperal surgical wounds].
Candotti, G; Dindelli, M; Frigerio, L; Pifarotti, G; Potenza, MT,
)
0.13
" Oral granules of nimesulide were administered in daily dosage of 200 mg."( [Controlled clinical study of the efficacy and tolerability of methoxybutropate compared to nimesulide in gynecology].
Ajossa, S; Guerriero, S; Mais, V; Melis, GB; Paoletti, AM, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (63.64)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.08 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (35.71%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]